Earnings

Uncovering the next great stocks: New Gold Inc. (NGD), Corcept Therapeutics Incorporated (CORT)

The shares of New Gold Inc. have decreased by more than -37.39% this year alone. The shares recently went down by -1.44% or -$0.03 and now trades at $2.06. The shares of Corcept Therapeutics Incorporated (NASDAQ:CORT), has slumped by -16.00% year to date as of 07/12/2018. The shares currently trade at $15.17 and have been able to report a change of 3.20% over the past one week.

The stock of New Gold Inc. and Corcept Therapeutics Incorporated were two of the most active stocks on Thursday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Next 5Y EPS Growth: 10.96% versus -4.90%

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that NGD will grow it’s earning at a 10.96% annual rate in the next 5 years. This is in contrast to CORT which will have a positive growth at a -4.90% annual rate. This means that the higher growth rate of NGD implies a greater potential for capital appreciation over the years.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. The ROI of NGD is -3.00% while that of CORT is 85.00%. These figures suggest that CORT ventures generate a higher ROI than that of NGD.

Cash Flow



The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, NGD’s free cash flow per share is a positive -0, while that of CORT is positive 0.02.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for NGD is 2.80 and that of CORT is 5.40. This implies that it is easier for NGD to cover its immediate obligations over the next 12 months than CORT. The debt ratio of NGD is 0.48 compared to 0.00 for CORT. NGD can be able to settle its long-term debts and thus is a lower financial risk than CORT.

Valuation

NGD currently trades at a forward P/E of 15.49, a P/B of 0.56, and a P/S of 1.83 while CORT trades at a forward P/E of 9.72, a P/B of 8.11, and a P/S of 9.32. This means that looking at the earnings, book values and sales basis, NGD is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions




The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of NGD is currently at a -45.93% to its one-year price target of 3.81. Looking at its rival pricing, CORT is at a -35.72% relative to its price target of 23.60.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), NGD is given a 2.70 while 2.40 placed for CORT. This means that analysts are more bullish on the outlook for NGD stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for NGD is 1.64 while that of CORT is just 15.39. This means that analysts are more bullish on the forecast for NGD stock.

Conclusion

The stock of New Gold Inc. defeats that of Corcept Therapeutics Incorporated when the two are compared, with NGD taking 6 out of the total factors that were been considered. NGD happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, NGD is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for NGD is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

Which of these 2 stocks can turn out to be absolut... The shares of Allergan plc have increased by more than 12.48% this year alone. The shares recently went up by 3.01% or $5.37 and now trades at $183.99...
Are These Stocks A Sure Bet? – Cerner Corpor... The shares of Cerner Corporation have decreased by more than -3.12% this year alone. The shares recently went up by 0.66% or $0.43 and now trades at $...
Uncovering the next great stocks: Corcept Therapeu... The shares of Corcept Therapeutics Incorporated have decreased by more than -32.06% this year alone. The shares recently went down by -7.47% or -$0.99...
Which Market Offer More Value? – HD Supply H... The shares of HD Supply Holdings, Inc. have increased by more than 6.62% this year alone. The shares recently went down by -0.77% or -$0.33 and now tr...
Reliable Long-term Trend to Profit From: Carter... The shares of Carter's, Inc. have decreased by more than -20.09% this year alone. The shares recently went down by -1.94% or -$1.86 and now trades at ...